Brain, Behavior, and Cancer Seminar Series January 16, 2013, 10:00 am - 11:00 am Hillman Cancer Center, Cooper Conference Room C
Psychobiology of Posttraumatic Stress Disorder
across the Lifespan
Douglas L. Delahanty, PhD
Professor, Department of Psychology
Director, Initiative for Clinical and Translational Research
Kent State University
Dr. Douglas Delahanty is an expert in the area of early biopsychological predictors of PTSD and has extensive experience assessing traumatic experiences and posttraumatic stress disorder (PTSD) symptoms in children and adults recruited within hours following traumatic injury. He earned his PhD in Health Psychology from the University of Pittsburgh in 1997 and is now a Professor of Psychology at Kent State University and Director of the Kent State Initiative for Clinical and Translational Research (ICTR). Dr. Delahanty's research has identified numerous risk factors for adverse consequences of trauma exposure. His group's applied translational projects have focused on developing interventions to reduce/prevent PTSD and comorbid disorders. Among their recent research efforts are a large-scale NIMH-funded study (R01 MH62042) that examined psychophysiological predictors and correlates of PTSD in MVA victims, and resulted in a series of published studies examining predictors and moderators of PTSD in pediatric trauma victims. He and his research team also have conducted two pharmacological interventions for secondary prevention of PTSD in trauma patients; one funded by the Ohio Board of Regents that examined the efficacy of propranolol for reducing/preventing PTSD in child trauma victims (Nugent et al., 2010), and another study funded by the National Institute of Mental Health examining the efficacy of hydrocortisone at reducing/preventing PTSD in adult trauma victims. In addition to these projects, Dr. Delahanty has also served as Principal Investigator of a project to treat chronic PTSD using prolonged exposure in people living with HIV (R34 MH71201).
The Brain, Behavior, and Cancer Seminar Series is sponsored by the Biobehavioral Medicine in Oncology Program and the University of Pittsburgh Cancer Institute. For more information regarding this seminar, please contact Dolores Oliver at email@example.com. The Cooper Classrooms are located on the ground level of the Hillman Cancer Center, 5115 Centre Ave, Shadyside. After entering the building walk to the left past the elevators and gift shop and make the first left down the hallway. Room A is the 1st door in the lobby area.
Parking is available in the garage at the UPMC Cancer Pavilion across the street from the Hillman Cancer Center (~$6 cash/credit for 1-2 hours). There are also parking meters along Centre Avenue, Cypress Street and Baum Boulevard in the blocks surrounding the Cancer Center. The 71A & 71C both travel from Oakland and stop at Cypress Street just beyond the Cancer Center entrance. UPMC and Pitt shuttles also run between Oakland and Shadyside: http://www.pc.pitt.edu/transportation/routes.html http://www.upmc.com/patients-visitors/visitor-info/Documents/blue-shuttle-schedule.pdf